| LFC | treatment | description | class of inhibitor | 
| -0.244 | Amikacin | ug/mL Amikacin | translation | 
| -0.915 | Cap | 5-10ug/mL Capreomycin | translation | 
| -0.344 | Rox | 10-50 ug/mL Roxithromycin | translation | 
| -0.487 | SM | 2-5 ug/mL Streptomycin | translation | 
| -0.906 | Tet | 5-10 ug/mL Tetracycline | translation | 
| -0.224 | Rif | 0.2-5ug/mL Rifampicin | transcription | 
| -0.392 | Rifp | 0.1-0.5ug/mL Rifapentine | transcription | 
| -0.409 | Min_med__succinate_ | Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerol | starvation | 
| 4.127 | CCCP | 10-50 uM Carbonyl cyanide 3-chlorophenylhydrazone | respiration | 
| -0.347 | CPZ | 10-50 ug/mL Chlorpromazine | respiration | 
| -0.130 | Clofazimine | 10-13 ug/mL Clofazimine | respiration | 
| -0.008 | Clotrimazole | 10-24 ug/mL Clotrimazole (azole drug) | respiration | 
| -0.032 | DCCD | 20-100 uM Dicyclohexylcarbodiimide | respiration | 
| 2.864 | DNP | "0.5-2.5 mM 2,4-Dinitrophenol" | respiration | 
| 0.080 | DTT | "1-2 mM 1,4-Dithio-DL-threitol" | respiration | 
| -0.409 | Econazole | 10-24 ug/mL Econazole (azole drug) | respiration | 
| -0.433 | GSNO_CFZ | 0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofazimine | respiration | 
| -0.388 | GSNO_CPZ | 0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazine | respiration | 
| 0.298 | GSNO_KCN | 0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyanide | respiration | 
| -0.051 | GSNO_menadione | 0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadione | respiration | 
| 0.807 | KCN | 5-20 ug/mL Potassium cyanide | respiration | 
| -0.372 | NaN3 | 0.2-2 mM Sodium azide | respiration | 
| -0.330 | Nigericin | 50 uM Nigericin | respiration | 
| 3.792 | TRC | 10-150 ug/mL Triclosan | respiration | 
| -0.530 | TRZ | 10-25 ug/mL Thioridazine | respiration | 
| 0.008 | Valinomycin | 0.5-10 uM Valinomycin | respiration | 
| -0.333 | ZnSO4 | 2 mM ZnSO4 | respiration | 
| -0.185 | menadione | 6-10 ug/mL Menadione | respiration | 
| -0.272 | Ascididemin_Nat_prod | 4-9 ug/mL Organic extract of Eudistoma amplum | ironLimitation | 
| -0.525 | Deferoxamine | 150-250 uM Deferoxamine mesylate | ironLimitation | 
| -0.324 | Dipyridyl | "100-200 uM 2,2'-Bipyridyl" | ironLimitation | 
| -0.346 | GSNO | 0.02-0.1mM S-Nitrosoglutathione | dosRassociated | 
| -0.627 | NRP_1 | Non-replicating persistence stage 1 | dosRassociated | 
| -0.559 | Amp | 0.2mg/mL Ampicillin | cellWall | 
| -0.302 | Cephalexin | 20-100 ug/mL Cephalexin | cellWall | 
| -0.203 | Cerulenin | 0.32-5 ug/mL Cerulenin | cellWall | 
| -0.527 | DIPED | 5-100 ug/mL Diisopropylethylenediamine | cellWall | 
| -0.376 | EMB | 10-20 ug/mL Ethambutol | cellWall | 
| -0.680 | Eta | 12-40 ug/mL Ethionamide | cellWall | 
| -0.593 | INH | 0.2-0.4 ug/mL Isoniazid | cellWall | 
| -0.090 | TLM | 0.1-0.2 mg/mL Thiolactomycin | cellWall | 
| -0.542 | Palmitate | Minimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole Csource | carbonSource | 
| -0.285 | Succinate | Minimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole Csource | carbonSource | 
| 0.136 | BZA | 0.12 mg/mL Benzamide | aromaticAmides | 
| -0.014 | Nam | 0.12 - 1.2 mg/mL Nicotinamide | aromaticAmides | 
| -0.102 | PZA | 0.12-1.2 mg/mL Pyrazinamide | aromaticAmides | 
| 0.067 | H2O2 | 4 mM hydrogen peroxide | DNAdamaging | 
| -0.199 | Levo | 10 ug/mL Levofloxacin | DNAdamaging | 
| -0.116 | Mtm | 0.1-0.2 ug/mL Mitomycin C | DNAdamaging | 
| -0.709 | Novobiocin | 10 ug/mL Novobiocin | DNAdamaging | 
| -0.368 | Oflox | 5-10 ug/mL Ofloxacin | DNAdamaging | 
| -0.374 | UV | UV-irradiation | DNAdamaging | 
| 2.336 | ARP4 | 1-4 ug/mL Antitubercular compound ARP4 | ? | 
| -0.331 | Antimycin | 12.5-50 ug/mL Antimycin A | ? | 
| -0.047 | DTNB | "1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)" | ? | 
| -0.392 | PA_1 | 10-50 ug/mL Antitubercular compound PA-1 | ? | 
| -0.550 | PA_21 | 10-50 ug/mL Antitubercular compound PA-21 | ? | 
| 0.665 | PA824 | 0.2-2 ug/mL PA-824 | ? | 
| -0.159 | Procept_6776 | 20-30 ug/mL Antitubercular compound Procept 6776 | ? | 
| -0.137 | Procept_6778 | 5-40 ug/mL Antitubercular compound Procept 6778 | ? | 
| -0.143 | Verapamil | 50 uM Verapamil | ? | 
| -0.318 | mercaptoethanol | 2 mM 2-Mercaptoethanol | ? | 
| -0.366 | methoxatin | 10-20 ug/mL Methoxatin | ? |